Born as a UGent spin-off in 2018, Avroxa has become a key industrial partner for the development and production of biocompatible polymers, both in R&D and cGMP quality.

Through our distinct product lines, we deliver the optimal polymer for drug, biologics and gene formulation, nanomedicines, ADCs and more.

Our Ultroxa® polymers constitute an ideal PEG replacement, with many additional benefits and functionalities, while our UltraPEI® polymers enable effective transfection and delivery of nucleic acids -both RNA and DNA-.

Click here to know more!